Insight

Infection Prevention and Management after CAR T Cell Therapy for Hematological Malignancies

Photo taken from www.acs.org

Aug 1, 2024, 03:35

Infection Prevention and Management after CAR T Cell Therapy for Hematological Malignancies

at Alfaisal University, shared a paper Zainab Shahid et al. on X, adding:

“Best Practice Considerations by The American Society of Transplant and Cellular Therapy:

Infection Prevention and Management after Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies.”

Source: Mostafa Faisal/X

Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management after Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies.

Authors: Zainab Shahid, Tania Jain, Veronica Dioverti, Martini Pennisi, Lekha Mikkilineni, Swetha Kambhampati, Nirali N Shah, Sanjeet Dadwal, Genovefa Papanicolaou, Mehdi Hamadani, Paul A. Carpenter, Gabriela Maron Alfaro, Susan K. Seo, and Joshua A. Hill.

Management

cancer Gabriela Maron Alfaro Genovefa Papanicolaou hematological malignancies Infection Prevention Joshua A. Hill Lekha Mikkilineni Martini Pennisi Mehdi Hamadani Mostafa Faisal Nirali N Shah OncoDaily Oncology Paul A. Carpenter Sanjeet Dadwal Susan K. Seo Swetha Kambhampati T-cell therapy Tania Jain The American Society of Transplant and Cellular Therapy Veronica Dioverti Zainab Shahid

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage